glp 1 agonist and dpp 4 inhibitor DPP4 Mechanism of Action – My Endo Consult Cardiovascular effects of DPP-4 inhibition:
Description
Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea
Despite Wegovy and Zepbound being approved for patients with a body mass index of 30 or greater, and 27 or greater for those with at least one weight-related ailment, some insurance plans require a higher BMI or additional criteria for coverageif they cover medications for obesity at all
GIP receptor agonists mimic a similar polypeptide found in the body, which stimulates insulins response to food, perhaps even more than their GLP-1 counterparts
Tao et al., 2019)
Yan S, Marguet D, Dobers J, Reutter W, Fan H
The weight loss effects were discovered as a beneficial side effect, and many doctors now prescribe it off-label for weight management
